Status:
COMPLETED
Performances Evaluation of New FibroScan Probes Dedicated to Morbidly Obese Patients
Lead Sponsor:
Echosens
Conditions:
Obesity, Morbid
Liver Fibrosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Non-Alcoholic Fatty Liver is a common clinical and histological condition associated with metabolic syndrome in patients with and without excess body weight. It represents the most common cause of liv...
Eligibility Criteria
Inclusion
- Patient must be at least 18 years old
- Patient must be able to give written informed consent
- Patient affiliated to a social security system
- Patients participating in the standard bariatric surgery care program (bariatric surgery criteria defined with BMI ≥ 40 kg / m² or patients with BMI ≥ 35 kg / m² and at least 1 associated co-morbidity
Exclusion
- Patient with presence of ascites
- Patients with exclusion criteria for bariatric surgery
Key Trial Info
Start Date :
September 19 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 24 2022
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT03872024
Start Date
September 19 2019
End Date
March 24 2022
Last Update
August 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital la Pitié Salpêtrière
Paris, France, 75013